Skip to content
Get alerts
GovInfoNow
Stop using now Drug recall · FDA · Published November 17, 2020

MPM Medical Recalls Lidocaine Hydrogel Due to Bacterial Contamination

MPM Medical recalls lidocaine hydrogel products contaminated with Burkholderia cepecia bacteria. Consumers should stop using affected items to avoid infection risks.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0118-2021DrugMPM Medical ›
Take action

Contact the company

Recalling firmMPM Medical LLC1801 Big Town Blvd Ste 300 · Mesquite, TX 75149-1030
✎ GovInfoNow plain-language explainer

MPM Medical is recalling lidocaine hydrogel products that were found to contain harmful bacteria. Using these products could lead to infections, so affected consumers should stop using them immediately. Read more at govinfonow.com/recall/36681-mpm-medical-recalls-lidocaine-hydrogel-due-to-bacterial-contamination.

Source Summary by GovInfoNow · govinfonow.com/recall/36681-mpm-medical-recalls-lidocaine-hydrogel-due-to-bacterial-contamination · Updated October 4, 2026 · FDA enforcement record: FDA #D-0118-2021

Cite this page

“MPM Medical Recalls Lidocaine Hydrogel Due to Bacterial Contamination.” GovInfoNow, updated October 4, 2026. https://govinfonow.com/recall/36681-mpm-medical-recalls-lidocaine-hydrogel-due-to-bacterial-contamination. Based on FDA recall #D-0118-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0118-2021%22&limit=1).

The FDA announced on November 17, 2020, that MPM Medical LLC is recalling REGENECARE HA (Lidocaine HCL 2%) Topical Anesthetic Hydrogel due to microbial contamination with Burkholderia cepacia. The agency classified the Class I recall as voluntary.

How to tell if you have it

  • Brand: MPM Medical
  • Product: REGENECARE HA (Lidocaine HCL 2%) Topical Anesthetic Hydrogel, Net Wt. 3 oz. (85 g)
  • NDC: 66977-107-03
  • Lot: 41262
  • Expiration Date: 01/21

The hazard

The product was found to be contaminated with the bacteria Burkholderia cepacia. This contamination poses a risk of infection for users of the non-sterile drug product.

Context

GovInfoNow's records show other recent recalls of similar products include Asclemed Lidocaine HCl Injection Recall (2026-06-08) and Keystone Pearson Topical Anesthetic Gel Recall (2026-05-21). Keystone DHP Topical Anesthetic Gel Recall also occurred on 2026-05-21.

How to tell if you have this one

Check for the product name 'REGENECARE HA (Lidocaine HCL : 2%) Topical Anesthetic Hydrogel' with a 3 oz. (85 g) size. The lot number 41262 and expiration date 01/21 are also indicators of the affected batch.

  • Brand
    MPM Medical
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop Using It Now

    Immediately stop using the recalled lidocaine hydrogel products to avoid infection risks.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Distributed Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 22 months after the firm started it.

1. Firm started the recall: Nov 17, 202012. FDA classified it Class I: Dec 7, 202023. Published in FDA’s Enforcement Report: Dec 9, 202034. FDA terminated the recall: Sep 8, 2022420202022
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

DermaRite PeriGiene Antiseptic Recall: Bacterial Contamination Risk
DermaRiteAmerican Health Packaging Recalls Metoclopramide Tablets Due to Foreign Drug Presence
American Health PackagingTeva Recalls Metoclopramide Tablets Due to Foreign Contaminants
Teva Pharmaceuticals USA, IncPreferred Pharma Recalls Lidocaine Ointment Due to Content Issues
Preferred Pharmaceuticals, Inc.Northstar Rx Recalls Tretinoin Cream Due to Impurities
SUN PHARMACEUTICAL INDUSTRIES INC

Latest drug recalls

Apothecary Pharma LLC recalls Tirzepatide Injection, 18mg/mL, 4 mL Sterile Multi-Dose Vial, Rx only, Apothecary Pharma, LLC, 1913 Evans Road, Cary,
Apothecary Pharma · September 24, 2026Apotex Corp. recalls Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario,
Apotex · September 23, 2026Cipla USA, Inc. recalls Fosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-Dose Sachet, Rx
Cipla USA · September 18, 2026Ajanta Pharma USA Inc recalls Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc.,
Ajanta Pharma · September 17, 2026Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company recalls Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) with
Insight Pharmaceuticals · September 15, 2026K.C. Pharmaceuticals, Inc. recalls Sterile Lubricant Dry Eye Relief Eye Drops, 0.5 FL OZ (15 mL); a) LEADER, DISTRIBUTED BY CARDINAL HEALTH, DUBLIN, OHIO
Leader / TopCare / Crocodile Tears · September 11, 2026

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0118-2021 (November 17, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0118-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on October 4, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA